Beese Fulmer Investment Management, Inc. Amgen Inc Transaction History

Beese Fulmer Investment Management, Inc.

$1.14 Billion
Q3 2024

A detailed history of Beese Fulmer Investment Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Beese Fulmer Investment Management, Inc. holds 3,613 shares of AMGN stock, worth $1.06 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

3,613

Previous 3,783 4.49%

Holding current value

$1.06 Million

Previous $1.18 Million 1.44%

% of portfolio

0.1%

Previous 0.11%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$309.38 - $337.38 $52,594 - $57,354	-170 Reduced 4.49%	3,613 $1.16 Million
Q2 2024 Jul 03, 2024	BUY	$262.75 - $319.31 $22,333 - $27,141	85 Added 2.3%	3,783 $1.18 Million
Q1 2024 Apr 08, 2024	SELL	$268.87 - $324.56 $36,835 - $44,464	-137 Reduced 3.57%	3,698 $1.05 Million
Q4 2023 Jan 09, 2024	BUY	$255.7 - $288.46 $12,785 - $14,422	50 Added 1.32%	3,835 $1.1 Million
Q2 2023 Jul 11, 2023	BUY	$214.27 - $253.37 $64,281 - $76,011	300 Added 8.61%	3,785 $840,000
Q1 2023 Apr 11, 2023	SELL	$225.79 - $275.2 $3,161 - $3,852	-14 Reduced 0.4%	3,485 $842,000
Q4 2022 Jan 17, 2023	SELL	$229.03 - $291.01 $8,016 - $10,185	-35 Reduced 0.99%	3,499 $0
Q3 2022 Oct 06, 2022	BUY	$224.46 - $253.15 $2,244 - $2,531	10 Added 0.28%	3,534 $797,000
Q2 2022 Jul 11, 2022	BUY	$230.71 - $256.74 $12,458 - $13,863	54 Added 1.56%	3,524 $857,000
Q1 2022 Apr 12, 2022	BUY	$219.27 - $242.57 $36,179 - $40,024	165 Added 4.99%	3,470 $839,000
Q4 2021 Jan 10, 2022	BUY	$198.88 - $227.6 $28,240 - $32,319	142 Added 4.49%	3,305 $743,000
Q3 2021 Oct 08, 2021	BUY	$212.27 - $248.7 $260,030 - $304,657	1,225 Added 63.21%	3,163 $673,000
Q2 2021 Jul 08, 2021	BUY	$233.58 - $259.14 $58,395 - $64,785	250 Added 14.81%	1,938 $472,000
Q1 2021 Apr 23, 2021	BUY	$221.91 - $258.6 $77,668 - $90,510	350 Added 26.16%	1,688 $420,000
Q4 2020 Jan 20, 2021	BUY	$216.38 - $257.67 $5,409 - $6,441	25 Added 1.9%	1,338 $308,000
Q3 2020 Oct 08, 2020	SELL	$234.65 - $260.95 $58,662 - $65,237	-250 Reduced 15.99%	1,313 $334,000
Q3 2019 Nov 01, 2019	BUY	$174.11 - $208.62 $272,133 - $326,073	1,563 New	1,563 $302,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beese Fulmer Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beese Fulmer Investment Management, Inc. with notifications on news.

Account

Beese Fulmer Investment Management, Inc. Amgen Inc Transaction History